(Q51733621)

11 April 2018

title

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. (English)

1 reference

11 April 2018

main subject

patient

0 references

author

Elisabeth Müller-Holzner

6

object named as

Elisabeth Müller-Holzner

1 reference

11 April 2018

Günter Daxenbichler

8

object named as

Günter Daxenbichler

1 reference

11 April 2018

Alois Schneitter

4

object named as

Alois Schneitter

1 reference

11 April 2018

author name string

Georg Göbel

1

1 reference

11 April 2018

Doris Auer

2

1 reference

11 April 2018

Inge Gaugg

3

1 reference

11 April 2018

Ralf Lesche

5

1 reference

11 April 2018

Christian Marth

7

1 reference

11 April 2018

language of work or name

English

0 references

publication date

8 January 2011

1 reference

11 April 2018

Breast Cancer Research and Treatment

published in

1 reference

11 April 2018

volume

130

1 reference

11 April 2018

issue

1

1 reference

11 April 2018

page(s)

109-117

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1007/s10549-010-1335-8

exact match

0 references

cites work

Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

The RASSF1A tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaborati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

PITX2 is required for normal development of neurons in the mouse subthalamic nucleus and midbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Expression of the members of the Ptx family of transcription factors in human pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

The prognostic impact of bone marrow micrometastases in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1335-8

10.1007/S10549-010-1335-8

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

PubMed ID

21221769

1 reference

11 April 2018